We are live on ! Find out more
ECM

Everence Capital Management Portfolio holdings

AUM $1.64B
1-Year Est. Return 26.46%
This Fund
S&P 500
This Quarter Est. Return
+5.85%
1 Year Est. Return
+26.46%
3 Year Est. Return
+80.44%
5 Year Est. Return
+106.59%
10 Year Est. Return
+436.91%
AUM
$270M
AUM Growth
+$16M
Cap. Flow
+$2.67M
Cap. Flow %
0.99%
Top 10 Hldgs %
18.47%
Holding
276
New
10
Increased
19
Reduced
6
Closed
5

Top Buys

Rank Stock Value
1
GM icon
General Motors
GM
+$427K
2
VZ icon
Verizon
VZ
+$325K
3
LLY icon
Eli Lilly
LLY
+$229K
4
EW icon
Edwards Lifesciences
EW
+$213K
5
CTXS
Citrix Systems Inc
CTXS
+$208K

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$707K
2
FRX
FOREST LABORATORIES INC
FRX
+$420K
3
WFM
Whole Foods Market Inc
WFM
+$250K
4
NBR icon
Nabors Industries
NBR
+$247K
5
NVDA icon
NVIDIA
NVDA
+$211K

Sector Composition

Rank Sector Weight
1 Technology 16.94%
2 Financials 15.92%
3 Healthcare 14.21%
4 Communication Services 10.2%
5 Energy 9.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CMG icon
176
Chipotle Mexican Grill
CMG
$43.9B
$468K 0.17%
39,500
– –
CB icon
177
Chubb
CB
$140B
$458K 0.17%
4,420
– –
NUE icon
178
Nucor
NUE
$58.3B
$458K 0.17%
9,290
– –
STT icon
179
State Street
STT
$48.4B
$457K 0.17%
6,792
– –
HUM icon
180
Humana
HUM
$43.9B
$455K 0.17%
3,560
– –
SYK icon
181
Stryker
SYK
$135B
$441K 0.16%
5,228
– –
GIS icon
182
General Mills
GIS
$20.2B
$440K 0.16%
8,384
– –
DO
183
DELISTED
Diamond Offshore Drilling
DO
$430K 0.16%
8,672
– –
VTRS icon
184
Viatris
VTRS
$20.8B
$429K 0.16%
8,313
– –
CERN
185
DELISTED
Cerner Corp
CERN
$425K 0.16%
8,234
– –
XYL icon
186
Xylem
XYL
$28.5B
$414K 0.15%
10,598
– –
ADSK icon
187
Autodesk
ADSK
$51.8B
$411K 0.15%
7,286
– –
PRGO icon
188
Perrigo
PRGO
$1.44B
$411K 0.15%
2,823
– –
BSX icon
189
Boston Scientific
BSX
$68.4B
$410K 0.15%
32,126
– –
PAYX icon
190
Paychex
PAYX
$43.4B
$401K 0.15%
9,654
– –
LUMN icon
191
Lumen
LUMN
$6.43B
$392K 0.15%
10,818
– –
RDC
192
DELISTED
Rowan Companies Plc
RDC
$390K 0.14%
12,205
– –
SYY icon
193
Sysco
SYY
$40.8B
$389K 0.14%
10,383
– –
WDC icon
194
Western Digital
WDC
$159B
$389K 0.14%
5,580
– –
APTV icon
195
Aptiv
APTV
$12.3B
$387K 0.14%
5,636
– –
ICE icon
196
Intercontinental Exchange
ICE
$87.2B
$387K 0.14%
10,235
– –
VRTX icon
197
Vertex Pharmaceuticals
VRTX
$123B
$386K 0.14%
4,082
– –
BRCM
198
DELISTED
BROADCOM CORP CL-A
BRCM
$380K 0.14%
10,225
– –
SHW icon
199
Sherwin-Williams
SHW
$83.5B
$379K 0.14%
5,490
– –
MJN
200
DELISTED
Mead Johnson Nutrition Company
MJN
$374K 0.14%
4,013
– –
6 7
8
9 10

Similar funds

LIA
LBMC Investment Advisors Brentwood, Tennessee $1.64B AUM 15.26% 1-Year Est. Return
GA
Greenspring Advisors Towson, Maryland $1.64B AUM
AHC
Adell Harriman & Carpenter Houston, Texas $1.64B AUM 36.77% 1-Year Est. Return
UMC
UNC Management Company Chapel Hill, North Carolina $1.64B AUM 17.65% 1-Year Est. Return
1SP
140 Summer Partners New York $1.64B AUM 47.44% 1-Year Est. Return
MRG
Milestone Resources Group Road Town Tortola, British Virgin Islands $1.64B AUM 7.52% 1-Year Est. Return
TIAA Trust, National Association
TIAA Trust, National Association Charlotte, North Carolina $1.65B AUM 16.63% 1-Year Est. Return
TCA
Troluce Capital Advisors Dorado, Puerto Rico $1.63B AUM 37.23% 1-Year Est. Return

Everence Capital Management's Q2 2014 Portfolio in Review

As of Q2 2014, Everence Capital Management held 276 positions worth $270M, up 6.3% from $254M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Everence Capital Management's Q2 2014 filing shows 10 new, 19 increased, 6 reduced and 5 closed positions. Its largest new stake was Edwards Lifesciences: 15,720 shares worth $225K. The largest sale was Celgene Corp, an estimated $707K.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • Everence Capital Management's largest Q2 2014 buy was Edwards Lifesciences: 15,720 shares worth $225K.
  • Everence Capital Management added most to General Motors in Q2 2014, an estimated $427K increase.
  • Everence Capital Management's biggest Q2 2014 reduction was Celgene Corp, cutting an estimated $707K.
  • Everence Capital Management fully exited FOREST LABORATORIES INC in Q2 2014, selling an estimated $420K.
  • Everence Capital Management's ten largest holdings make up 18% of its $270M portfolio in Q2 2014.
  • Everence Capital Management opened 10 new positions and closed 5 in Q2 2014.
  • Everence Capital Management's portfolio value rose 6.3% quarter-over-quarter to $270M.

Based on Everence Capital Management's 13F filing for Q2 2014, filed 4 Aug 2014.